市場調查報告書
商品編碼
1291590
空心膠囊市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Empty Capsules Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球空膠囊市場規模達到28億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到45億美元,在2023-2028年期間呈現7.5%的成長率(CAGR)。
空膠囊指的是封裝藥物的穩定外殼,以各種劑型在病人體內給藥,如顆粒劑和丸劑。它們在商業上有兩種不同的類型,明膠和非明膠。明膠膠囊(硬的和軟的)是一種高膠原蛋白的動物性藥品,由豬肉和牛肉及雞肉結締組織製造。另一方面,非明膠或素食膠囊是由澱粉和羥丙基甲基纖維素(HPMC)混合生產的。目前,空膠囊在保健和治療方面有廣泛的應用。
心血管疾病和慢性病發病率的增加以及老年人口的增加是推動空膠囊市場成長的一些關鍵因素。與此相呼應,為確保那些沒有接受膠囊藥物治療的患者的胃腸道安全而推出的膠囊中的膠囊技術是另一個促進成長的因素。此外,製造商對生產各種醫藥產品(如抗菌劑、抗酸劑、吸入劑、膳食補充劑、止痛劑和抗生素)的速釋膠囊的需求不斷上升,也促進了市場的成長。醫療保健行業的迅速擴張和非膠質膠囊的廣泛採用,如羥丙基甲基纖維素(HPMC),由於其適度的強度、透明度和抗油和脂肪的特性,正在推動市場成長。此外,醫療部門為引進創新療法和藥物而進行的研究和開發(R&D)活動的投資增加,也積極刺激了市場的成長。其他因素,如容易獲得先進的治療方案,空膠囊供應商和明膠製造商之間的戰略合作,以及對各種膳食補充劑、免疫增強劑和藥物的需求成長,都為市場創造了積極的前景。
The global empty capsules market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.
Empty capsules refer to a stable shell encapsulating medicines that are administered in the patient's body in various dosage forms, such as granules and pellets. They are commercially available in two varying types, gelatin and non-gelatin. The gelatin capsules (hard and soft) are a high collagen animal-based medicine manufactured from pig meat and beef and chicken connective tissues. On the other hand, the non-gelatin, or vegetarian capsule, is produced from the blend of starch and hydroxypropyl methylcellulose (HPMC). Currently, empty capsules find extensive applications in healthcare and therapeutic applications.
The increasing prevalence of cardiovascular and chronic diseases and the rising geriatric population are some of the key factors driving the empty capsule market growth. In line with this, the introduction of capsule-in-capsule technology to ensure gastrointestinal safety of those patients that did not receive capsule medication is another growth-inducing factor. Moreover, the rising demand for the immediate-release capsule by manufacturers for producing various medicinal products, such as antibacterial, antiacids, inhalers, dietary supplements, painkillers, and antibiotics, are contributing to the market growth. The rapid expansion in the healthcare industry and the widespread adoption of non-gelatin capsules, such as hydroxypropyl methylcellulose (HPMC) due to its moderate strength, transparency, and resistance to oil and fat properties, are propelling the market growth. Additionally, the increasing investments in the research and development (R&D) activities in the healthcare sector for introducing innovative therapeutics and pharmaceutical drugs is positively stimulating the market growth. Other factors, such as the easy access to advanced treatment options, strategic collaborations between the empty capsule suppliers and gelatin manufacturers, and the growing demand for various dietary supplements, immunity boosters, and drugs, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global empty capsules market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, raw material, functionality, therapeutic application and end user.
Gelatin Capsule
Non-gelatin Capsule
Pig Meat
Bovine Meat
Bone
Hydroxypropyl Methylcellulose (HPMC)
Others
Immediate-release Capsules
Sustained-release Capsules
Delayed-release Capsules
Antibiotic and Antibacterial Drugs
Vitamins and Dietary Supplements
Antacid and Antiflatulent Preparations
Cardiovascular Therapy Drugs
Others
Pharmaceutical Industry
Nutraceutical Industry
Cosmetics Industry
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd and Sunil Healthcare Limited.
Key Questions Answered in This Report
1. What was the size of the global empty capsules market in 2022?
2. What is the expected growth rate of the global empty capsules market during 2023-2028?
3. What are the key factors driving the global empty capsules market?
4. What has been the impact of COVID-19 on the global empty capsules market?
5. What is the breakup of the global empty capsules market based on the type?
6. What is the breakup of the global empty capsules market based on the raw material?
7. What is the breakup of the global empty capsules market based on the functionality?
8. What is the breakup of the global empty capsules market based on the end user?
9. What are the key regions in the global empty capsules market?
10. Who are the key players/companies in the global empty capsules market?